Specific Alu elements involved in a significant percentage of copy number variations of the  gene in patients with Peutz–Jeghers syndrome by unknown
ORIGINAL ARTICLE
Specific Alu elements involved in a significant percentage of copy
number variations of the STK11 gene in patients with Peutz–
Jeghers syndrome
Pawel Borun1 • Marina De Rosa2 • Boguslaw Nedoszytko3 • Jaroslaw Walkowiak4 •
Andrzej Plawski1
Published online: 5 April 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Peutz–Jeghers syndrome (PJS) is a rare her-
editary syndrome characterized by the occurrence of
hamartomatous polyps in the gastrointestinal tract, muco-
cutaneous pigmentation and increased risk of cancer in
multiple internal organs. PJS is preconditioned by the
manifestation of mutations in the STK11 gene. The ma-
jority of detected STK11 changes are small scale mutations,
however recent studies showed the significant contribution
of medium-sized changes commonly known as copy
number variations (CNVs). Here we present a novel 7001
bps deletion of STK11 gene fragment, in which we iden-
tified the presence of breakpoints (BPs) within the Alu
elements. Comparative meta-analysis with the 80 other
CNV cases from 12 publications describing STK11 muta-
tions in patients with PJS revealed the participation of
specific Alu elements in all deletions of exons 2–3 so far
described. Moreover, we have shown their involvement in
the two other CNVs, deletion of exon 2 and deletion of
exon 1–3 respectively. Deletion of exons 2–3 of the STK11
gene may prove to be the most recurrent large rearrange-
ment causing PJS. In addition, the sequences present in its
BPs may be involved in a formation of a significant
percentage of the remaining gene CNVs. This gives a new
insight into the conditioning of this rare disease and en-
ables improvements in PJS genetic diagnostics.
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Introduction
Peutz–Jeghers syndrome (PJS; OMIM 175200) is a pre-
disposition to the occurrence of pigment skin lesions and
hamartomatous polyps inherited in an autosomal dominant
way. The polyps may cause ileus and bleeding from the
lower part of the tract, if underwent autoamputation [1, 2].
Incidence of the syndrome ranges from 1/29,000 to
1/120,000 births [3]. Patients with PJS are at an elevated
risk of developing extra intestinal cancers located in the
pancreas, the breasts, the ovary and the uterus [4–6].
Peutz–Jeghers syndrome is preconditioned by the
manifestation of mutations in the STK11 (OMIM*602216
Serine/Threonine Protein Kinase 11) gene, located in the
short arm of chromosome 19, in the 13.3 region. The gene
consists of ten exons, nine of which code for a protein. The
majority of detected changes are small scale mutations,
however recent studies showed the contribution of large
rearrangements in a significant percentage of patients,
reaching in some groups even 30 % of all the detected
mutations [7, 8]. These medium-sized changes concerning
exons or larger genomic fragments are commonly known
as copy number variations (CNV) [9]. Literature indicates a
number of mechanisms involved in the formation of CNV
[10]. One of the hypotheses described assumes that a sig-
nificant proportion of large mutations occurs within the
interspersed repeats through non-allelic homologous
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recombination. Alu elements are a family of short inter-
spersed nuclear elements (SINE) and comprise about
10.5 % of the human genome [11]. There is an overrep-
resentation of such sequences in the STK11 gene [12]. Alu
elements, which represent 19 % of the entire gene se-
quence (24 kb), are concentrated mainly in the distal part
of the gene (especially in intron 1). In the following pub-
lication we present the case of a patient with a deletion of
STK11 gene fragment, in which we observed the presence
of breakpoints (BPs) within the Alu elements. We decided
to perform a meta-analysis of similar cases reported in the
literature, using the in silico analysis of the DNA sequence
of the STK11 gene.
Materials and methods
PJS family description
The proband is a 39 year-old woman (born in 1975), who
manifested pigmented lesions of the lips and buccal mu-
cosa during infancy. In preschool and school age pigmen-
tation increased, appearing around the mouth, on the
eyelids and around fingers. After puberty these signs
gradually subsided. Currently 39, she exhibits small muco-
cutaneous melanosis around the lips and eyelids. From the
age of 21 the patient has undergone surgery four times to
remove polyps from the stomach, small intestine and colon,
preceded by signs of mechanical obstruction and gas-
trointestinal bleeding. All removed polyps were hamar-
tomas with no signs of malignant transformation.
The proband’s mother also had pigmented lesions on the
lips and buccal mucosa. She underwent surgery twice (in
1985 and 2000) because of gastrointestinal polyps. All
observed polyps were also hamartomas with no signs of
malignant transformation. The proband’s grandmother died
from skin cancer of right groin, diagnosed as a melanoma
while her grandfather died aged 54 due to ‘‘twisted bowel’’
(lack of precise clinical data). PJS in the family has been
also diagnosed in the proband’s two children, sister and
nephew.
Study design
The material for research was DNA from peripheral blood.
The blood was collected in cooperation with the Depart-
ment of Dermatology of Gdansk Medical University. The
studies were approved by the local Ethics Committee of the
Poznan University of Medical Science and performed after
obtaining written informed consent from the patients. The
preliminary diagnostics using high resolution melting
(HRM) and single strand conformation polymorphism
(SSCP) showed no small mutations [13]. Subsequently, the
patient was examined for large rearrangements using
multiplex ligation-dependent probe amplification (MLPA)
method (SALSA MLPA kit P101-A2 [MRC Holland]),
which revealed decreased signals for probes hybridizing to
exons 2 and 3.
Location of interspersed repeats within the entire se-
quence (24 kbps) of the STK11 gene was determined on the
basis of bioinformatic analysis with the use of Re-
peatMasker software, version open-3.3.0 (www.repeatmas
ker.org).
Primer pair encompassing potentially involved Alu se-
quences within introns 1 and 3 was designed to identify the
exact location of mutation breakpoints. Primer sequences
were as follows: forward—50-TTCTGGTAGGCAGTGGG
TTC-30; reverse—50-TCACAGAAGTCCAGGCACAC-30.
The 8936 bps long PCR product was obtained through
Long-range PCR using Advantage Genomic LA Poly-
merase [Clontech]. Long-range PCR conditions were as
follows: 94 C for 1 min, and then 30 cycles of 94 C for
30 s, and 68 C for 13.5 min, and finally 72 C for 10 min.
The 25-lL reaction volume contained 100 ng of DNA and
5 pmol of each primer. PCR products were separated on
1 % agarose gel [Sigma Aldrich] electrophoresis in 1x
TBE buffer. The shorter (approximately 2000 bps) product
was directly sequenced by Sanger method using ABI 373
DNA sequencer [Applied Biosystems] according to
manufacturer’s instructions.
Interspersed repeats alignment was conducted with the
use of basic local alignment search tool (BLAST) (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) optimized for somewhat
similar sequences (blastn). Sequence nomenclature used to
describe the breakpoints and interspersed repeats positions
was based on the UCSC Genome Browser Feb. 2009
(GRCh37/hg19). The nomenclature of all previously de-
scribed CNVs was converted for the purpose of publication
in accordance with the above-mentioned guidelines
(Tables 1, 2).
Meta-analysis
We performed a comparative analysis with the 80 CNV
cases of the STK11 gene from 12 publications describing
STK11 mutations in patients with PJS [7, 8, 12, 14–22].
Results
Breakpoint identification
Using the MLPA and sequencing we identified a 7001 bps
deletion c.280 ? 5594_464 ? 384del7001 co-segregating
with PJS phenotype in this family.
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The analysis of the STK11 gene sequence using Re-
peatMasker software revealed the presence of 20 inter-
spersed repeats, including 18 SINE/Alu and 2 LINE1
elements. Comparing the data from bioinformatic analysis
of the mutation sequence and the interspersed repeats
within the STK11 gene, we found that both mutation
breakpoints are located in Alu elements from AluY sub-
family, in regions [1,212,558–1,212,842] and
[1,219,530–1,219,843] respectively.
In silico analysis results
Deletion of exons 2 and 3 of the STK11 gene were ob-
served also in PJS patients from other populations
(Table 1). In several studies the exact breakpoint locations
of detected CNVs were determined, and the results indicate
the involvement of the same regions in the formation of all
detected deletions of exons 2 and 3 (Fig. 1).
For distal breakpoints (50) the participating region con-
tains three interspersed repeats next to each other (all from
class SINE and Alu family), respectively: AluY comprising
sequence [1,212,558–1,212,842] [for the sake of publica-
tion it is referred to as AluY(1)], FLAM_C comprising
sequence [1,212,850–1,212,978], and second AluY com-
prising sequence [1,212,891–1,213,195] [referred to as
AluY(2)]. All proximal breakpoints (30) are within the
same Alu element from AluY subfamily comprising se-
quence [1,219,530–1,219,843] [referred to as AluY(3)].
Table 1 Summary of the STK11 gene exons 2–3 deletions in other populations
Study Original mutation description Mutation
size






Our study c.280 ? 5594_464 ? 384del7001 7001 1,212,796 1,219,796 AluY(1) AluY(3)




1,213,168 1,219,550 AluY(2) AluY(3)
Italy II [15] 1,164,146–1,164,152
1,170,695–1,170,701
6549 1,213,146–1,213,152 1,219,695–1,219,701 AluY(2) AluY(3)
Italy II [15] 1,164,240–1,164,248
1,170,788–1,170,796
6548 1,213,240–1,213,248 1,219,788–1,219,796 AluY(2) AluY(3)
Italy I [12] NC_000019.8:g.6998_13998del
(7 KB del. spanning exons 2–3)
p.E98_G115del
7000 1,212,795 1,219,795 AluY(1) AluY(3)
Hungary
[16]





Germany [7] c.291-?_464 ? ?del No data No data No data No data No data
Korea [17] – No data No data No data No data No data
UK [18] c.333-?_424 ? ?del No data No data No data No data No data
Netherlands
[19]
– No data No data No data No data No data
Australia [8] – No data No data No data No data No data
Australia [8] – No data No data No data No data No data







Distal BP (50) Proximal BP (30) Interspersed
repeat at 50 BP
Interspersed







15,572 1,204,146–1,204,173 1,219,719–1,219,746 AluSq AluY(3)
Chile
[14]
1,213,086–1,218,902 Exon 2 5816 1,213,086 1,218,902 AluY(2) None
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Subsequently, we performed an alignment of AluY(3)
sequence with the elements from 50 BP and all other in-
terspersed repeats within the gene located upstream (50)
from AluY (3). The analysis showed a high complemen-
tarity of AluY(3) to AluY(1)—232/295 (79 %),
FLAM_C—84/112 (75 %) and AluY(2)—272/305 (89 %)
and the position of all the above mentioned elements in the
same orientation.
Summary of clinical data
The phenotype of deletion carriers is generally typical for
PJS (Table 3). All probands except one (diagnosed at the
age of 1) had a characteristic pigmentation and
hamartomatous polyps. Polyps in the stomach were ob-
served in 25 % of the cases, and a single proband had nasal
polyps. The age of diagnosis is varied. The course of dis-
ease in this group is not particularly severe. The available
data show that among the probands occurrence of cancer
has not been observed. In our proband’s family, melanoma
occurred only in her grandmother.
Discussion
Molecular studies of genetic diseases rely on methods able
to detect both small sequence variants (point mutations,
etc.) and rearrangements of larger genomic fragments.
Fig. 1 Approximate location of
each STK11 exons 2–3 deletion
with identified breakpoint
positions. Mutation order
corresponds to the description in
Table 1
Table 3 Summary of clinical data of the STK11 exons 2–3 deletion carriers
Patient Gender Age at diagnosis Pigmentation Hamartomatous polyps Polyps localization Cancer
Our study F 21 Yes Yes Stomach, small intestine, colon No
Chile [14] F 34 Yes Yes Small intestine, colon No
Italy II [15] M 4 Yes Yes Stomach, small intestine, colon No
Italy II [15] M 1 No Yes Stomach, small intestine, colon No
Italy I [12] N/A 5 Yes Yes Intestine N/A
Hungary [16] F 29 Yes Yes Small intestine N/A
Germany [7] N/A N/A Yes Yes N/A N/A
Korea [17] N/A N/A N/A Yes N/A N/A
UK [18] M 15 N/A N/A N/A No
Netherlands [19] N/A N/A N/A Yes Intestine, nasal cavity N/A
Australia [8] F 13 Yes Yes N/A N/A
Australia [8] F 35 Yes Yes N/A N/A
N/A data not available, F female, M male
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Screening methods, along with direct sequencing, can
identify the majority of small mutations. Copy number
variations are a greater challenge and the methods used for
their detection do not always allow researchers to deter-
mine the exact sequence undergoing mutation (e.g. MLPA,
Quantitative-PCR, Array-CGH, C-HRM) [23–26]. These
approaches not only fail to identify the exact breakpoint but
also prevent any further examination of possible mechan-
isms involved in their formation.
In our study we have detected deletion of exons 2–3 of
the STK11 gene in a family with PJS and determined the
breakpoints of the mutation. Similar mutations had been
described in studies of PJS patients from other populations.
Among them 11 were deletions encompassing exons 2 and
3. Exact breakpoints were identified in five cases only,
while the remaining ones provided no information on the
size and exact location of the change. All six cases de-
scribed (including our patient) are similar in terms of both
BP positions, 30 BPs in particular, which in all cases are
within the AluY(3) element. All distal breakpoints (50) are
also located in the same region, with the difference that in
silico analysis revealed the presence of three contiguous
interspersed repeats: AluY(1), FLAM_C and AluY(2), re-
spectively. All the above elements belong to the SINE class
and Alu family. Although 50 BPs of changes are not exactly
in the same element, it can be assumed that the whole
region is involved in the formation of CNV, and the BP
position is merely the result of non-specific DNA repair.
Involvement of Alu elements in all mutations analyzed
may confirm De Rosa’s hypothesis that non-allelic ho-
mologous recombination mediated by Alu elements is a
factor causing the formation of deletions of exons 2–3 in
the STK11 gene [12]. Moreover, this mechanism seems to
be recurrent (Fig. 2).
Then we checked the complementarity between AluY(3)
and other interspersed repeats present in the gene upstream
from AluY(3). Sequence alignment showed high comple-
mentarity of AluY(3) to all elements from the distal BPs of
analyzed changes. Furthermore, distal as well as proximal
BPs are situated in the same orientation, which may be
crucial for the mechanism involved in their formation.
Of the 80 CNVs described in publications we analyzed
only 20 having determined breakpoints. Excluding five
deletions of exons 2–3, BPs in CNVs encompassing this
region were determined only for two changes that are:
deletion of exon 2 described in Chile and deletion of exons
1–3 in Italy (Table 2). Both these changes share one BP
with deletions of exons 2–3. Distal BP of exon 2 deletion is
within AluY(2), and proximal BP of exons 1–3 deletion is
in AluY(3) (Fig. 3). Of the total 21 CNVs with determined
BPs, 8 (over 38 %) exhibit participation of Alu elements
from these two regions.
Further analysis of the remaining 60 CNVs without
specified BPs showed that there are 13 additional changes
in which at least one BP is located in intron 1 or 3. It cannot
be excluded that in their formation Alu elements of interest
are involved. Of the 81 identified CNVs, 8 have confirmed
BPs in these regions, while the other 19 are changes with
their potential involvement. Hence, there are 27 conceiv-
able changes from 81 CNVs, which represent over 33 % of
all detected CNVs of the STK11 gene.
The increased prevalence of CNV in the gene can be
associated with the accumulation of interspersed repeats
including Alu, especially in the distal region, which has
already been observed and thoroughly discussed by Resta
et al. [15]. Of the 15 patients with CNV in their group, 7
had deletions caused by NAHR between Alu elements.
They defined an 18,019 bp-long region of the STK11 gene
as a recombination hotspot. Resta et al. indicated that the
repetitive elements have been implicated in chromosomal
aberrations because their presence increases instability of
the region. Our observations confirm this thesis,
Fig. 2 Possible CNV formation
based on Alu-mediated
homologous recombination
model. a STK11 gene structure,
b recombination event between
two homologous Alu sequences
and c gene structure after
recombination
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furthermore narrow recombination hotspot for deletions of
exons 2 and 3 to two regions, to the first with contiguously
grouped AluY(1), FLAM_C, AluY(2) in intron 1, and to
the second with a single copy of AluY(3) in intron 3.
Although Resta et al. consider the high density of Alu
elements as an important factor, they pointed out that it does
not seem sufficient to explain the high level of NAHR events
since several genes with high Alu content such as thymidine
kinase or beta-tubulin are not characterized by a high inci-
dence of this type of damage. They mention that character-
istic DNA motifs or additional features like high GC content
may contribute to the generation of recurrent rearrangements
of the STK11 gene. In our opinion, besides aforementioned
features, DNA methylation level may be considered as an-
other related factor. A few studies showed the association
between methylation status of repeat-rich regions and the
occurrence of recombination (cross over) events [27–29].
Those observations, which indicate that hypermethylation
may inhibit homologous recombination, might explain the
participation of specific Alus, despite the presence of closer
situated and highly homologous elements.
Concentration of CNV in the distal part of the gene led
us to the hypothesis of possible participation of intra-in-
tronic rearrangements of STK11 intron 1 in conditioning
PJS, in some cases with so far undetected genetic basis of
the disease. This 11,213-bp long fragment is located in the
STK11 recombination hotspot and characterized by the
highest accumulation of interspersed repeats within the
gene, reaching 43 % of its sequence (GC content 58 %). It
cannot be excluded that those rearrangements (either
deletions, duplications, or e.g. inversions) within the intron,
might interfere in the correct splicing or expression of
STK11 thereby conditioning PJS.
Deletion of exons 2–3 of the STK11 gene may prove to
be the most recurrent large rearrangement causing PJS.
Furthermore, its prevalence is not restricted to a particular
geographical region, but concerns the worldwide popula-
tion. In addition, the sequences present in its BPs may be
involved in a significant percentage of the remaining gene
CNVs. It is rather clear that there are multiple mechanisms
of CNVs formation, which include both recombination and
replication-based mechanisms. Thus, as reported, copy
number changes are not randomly distributed, but multiple
genomic features can affect the probability of their oc-
currence [10]. The data currently available unambiguously
suggest participation of Alu elements from the two studied
regions in all deletions of exons 2–3 so far described, and
we have also shown their involvement in the other two
mutations. Literature data indicate that approximately
30 % of PJS cases are caused by CNVs. According to our
study, a third involve Alu elements of interest, thus we can
assume that over 10 % of all PJS cases are related to the
mutations concerning those two regions. This gives a new
insight into the conditioning of this rare disease and allows
to introduce improvements in genetic diagnostics of the
patients.
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